Arjuna Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
11,892
-555
| -4% | -$67.2K | 0.38% | 60 |
|
|
2025
Q1 | $1.39M | Sell |
12,447
-659
| -5% | -$73.5K | 0.38% | 61 |
|
|
2024
Q4 | $1.28M | Sell |
13,106
-198
| -1% | -$19.3K | 0.34% | 70 |
|
|
2024
Q3 | $1.53M | Buy |
13,304
+69
| +0.5% | +$7.94K | 0.4% | 72 |
|
|
2024
Q2 | $1.41M | Buy |
13,235
+31
| +0.2% | +$3.3K | 0.38% | 65 |
|
|
2024
Q1 | $1.28M | Sell |
13,204
-9,927
| -43% | -$960K | 0.36% | 71 |
|
|
2023
Q4 | $2.34M | Buy |
23,131
+1,068
| +5% | +$108K | 0.73% | 42 |
|
|
2023
Q3 | $2.25M | Buy |
+22,063
| New | +$2.25M | 0.81% | 41 |
|
|
2021
Q4 | – | Sell |
-9,782
| Closed | -$800K | – | 109 |
|
|
2021
Q3 | $800K | Sell |
9,782
-170
| -2% | -$13.9K | 0.33% | 73 |
|
|
2021
Q2 | $908K | Buy |
9,952
+222
| +2% | +$20.3K | 0.39% | 75 |
|
|
2021
Q1 | $832K | Buy |
9,730
+437
| +5% | +$37.4K | 0.41% | 71 |
|
|
2020
Q4 | $878K | Buy |
9,293
+477
| +5% | +$45.1K | 0.49% | 58 |
|
|
2020
Q3 | $767K | Buy |
8,816
+142
| +2% | +$12.4K | 0.48% | 59 |
|
|
2020
Q2 | $758K | Buy |
8,674
+187
| +2% | +$16.3K | 0.52% | 53 |
|
|
2020
Q1 | $700K | Buy |
+8,487
| New | +$700K | 0.58% | 48 |
|
|
2019
Q2 | – | Sell |
-19,139
| Closed | -$1.65M | – | 100 |
|
|
2019
Q1 | $1.65M | Buy |
19,139
+309
| +2% | +$26.6K | 1.28% | 26 |
|
|
2018
Q4 | $1.45M | Sell |
18,830
-372
| -2% | -$28.6K | 1.32% | 27 |
|
|
2018
Q3 | $1.48M | Sell |
19,202
-194
| -1% | -$15K | 1.11% | 34 |
|
|
2018
Q2 | $1.31M | Sell |
19,396
-1,556
| -7% | -$105K | 1.07% | 37 |
|
|
2018
Q1 | $1.52M | Buy |
20,952
+294
| +1% | +$21.3K | 1.28% | 32 |
|
|
2017
Q4 | $1.55M | Buy |
+20,658
| New | +$1.55M | 1.46% | 27 |
|